4th Quarter - Report

SAREPTA THERAPEUTICS, INC. for SAREPTA THERAPEUTICS, INC.

Firm
Client
Income
—
Expenses
$230,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Patient Access to Treatments Newborn Screening for Rare Diseases

LobbyistCovered position, as disclosed
KIP PAYNE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Science/Technology SCI

Scientific Innovation in Healthcare Gene Therapies Rare Diseases Artificial Intelligence and Data Governance

LobbyistCovered position, as disclosed
KIP PAYNE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.